Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services

Contract Services

TG Therapeutics enters into global collaboration to develop Jubilant's novel BET inhibitor program TG Therapeutics unveiled that as part of a broader agreement with Indian biotechnology firm Jubilant Biosys, it has entered into a sub-license agreement with Checkpoint Therapeutics to develop and commercialize Jubilant's novel BET inhibitor program in the field of hematological malignancies.
Contract Research & Services > Contract Services > News
PDL BioPharma commits to equity investment in Noden Pharma PDL BioPharma has committed to an equity investment in Noden Pharma DAC, a new privately held company that has executed a purchase agreement with Novartis to acquire exclusive worldwide rights to manufacture, market, and sell the branded prescription medicine product sold under the name Tekturna and Tekturna HCT in the US and Rasilez and Rasilez HCT in the rest of the world.
Contract Research & Services > Contract Services > News BioPharma Services wins $20m contract from FDA's Center for Drug Evaluation and Research BioPharma Services USA, Inc. (BioPharma) has been awarded a 5-year, $20m contract with the Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA).
Contract Research & Services > Contract Services > News
See more Contract Services news

Latest Contract Services News and Insight

View all Contract Services news or find news targeted to your interests
MacroGenics, Janssen partner to develop new DART molecule for cancer treatment
By PBR Staff Writer
MacroGenics has licensed its preclinical cancer therapy MGD015 to Janssen Biotech under a global collaboration that may generate nearly $740m for the clinical-stage biopharmaceutical firm.
Contract Research & Services > Contract Services > News
McKesson and Walmart sign sourcing deal for generic pharmaceuticals
McKesson and Wal-Mart Stores have signed a sourcing agreement for generic pharmaceuticals and an expanded long-term distribution agreement.
Contract Research & Services > Contract Services > News
Biogen collaborates with University of Pennsylvania on multiple gene therapy programs
Biogen announced a broad collaboration and alliance with the University of Pennsylvania (“Penn”) to advance gene therapy and gene editing technologies.
Contract Research & Services > Contract Services > News
Sunshine Biopharma signs licensing deal for Anastrozole drug to treat breast cancer
Sunshine Biopharma has signed a Cross Referencing Agreement with a major pharmaceutical company for Anastrozole, a prescription generic drug for treatment of Breast Cancer.
Contract Research & Services > Contract Services > News
BioDelivery Sciences grants exclusive rights to develop ONSOLIS in US to Collegium
BioDelivery Sciences International (BDSI) has granted the exclusive rights to develop and commercialize ONSOLIS (fentanyl buccal soluble film) in the US to Collegium Pharmaceutical.
Contract Research & Services > Contract Services > News
Analytica 2016 at Messe München
Molnár-Institute opened the first day at analytica 2016 at Messe München in Munich, Germany. This year marks the 25th anniversary of Europe’s premier trade fair for laboratory technology, analysis and biotechnology.
Contract Research & Services > Contract Services > Press Releases
Alder licenses clazakizumab inflammation candidate rights to Vitaeris
By PBR Staff Writer
Alder BioPharmaceuticals has licensed exclusive worldwide rights to its inflammation candidate clazakizumab to Vitaeris for an undisclosed sum.
Contract Research & Services > Contract Services > News
Cardiome, Allergan sign XYDALBA licensing deal in international markets
Cardiome Pharma's affiliate has signed an exclusive license agreement with an affiliate of Allergan plc that will result in the Cardiome Group commercializing XYDALBA (Dalbavancin) in France, the U.K., Germany, Belgium, Nordic nations, certain other European nations (not already partnered), various Middle Eastern nations and Canada.
Contract Research & Services > Contract Services > News
BioQ Pharma expands US license and supply deal with Sandoz
BioQ Pharma has expanded its license and supply agreement with Sandoz, a division of Novartis, under which Sandoz now has the right to exclusively market an additional ready‐to‐use BioQ Pharma infusion pharmaceutical in the US.
Contract Research & Services > Contract Services > News
AstraZeneca sells US rights to gout drug Zurampic to Ironwood Pharmaceuticals
By PBR Staff Writer
AstraZeneca is selling the US rights to its gout treatment Zurampic (lesinurad) to Ironwood Pharmaceuticals.
Contract Research & Services > Contract Services > News
View all Contract Services news or find news targeted to your interests